Publication | Closed Access
Galantamine is a novel post-exposure therapeutic against lethal VX challenge
26
Citations
26
References
2009
Year
Molecular PharmacologyMedicineImmunologyLethal Vx ChallengeTherapeutic EfficacyExperimental TherapeuticPharmacotherapyPharmacologyNovel TherapyDrug Discovery
| Year | Citations | |
|---|---|---|
Page 1
Page 1